SCHEMBL4630952

SCHEMBL4630952

O=C(OCC1c2ccccc2-c2ccccc21)N1CCC(c2ccc(Br)cc2)(c2ncc(-c3ccccc3)o2)CC1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.37
OPRD1 P41143 13/20 0.37
OPRK1 P41145 7/20 0.36
OPRM1 P35372 1/20 0.36
FABP7 O15540 2/20 0.34
FABP5 Q01469 2/20 0.34
MDM4 O15151 1/20 0.33
TP53 P04637 1/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3489452 0.82 DPP8 (0.40) MDM2OPRD1FABP7FABP5MDM4
SCHEMBL3489451 0.78 KDM1A (0.34) MDM2FABP7FABP5MDM4TP53
SCHEMBL3015079 0.77 KMT2A (0.42) MDM2OPRD1OPRK1OPRM1FABP7
SCHEMBL3032315 0.76 HSD11B1 (0.47) MDM2FABP7FABP5TP53LMNA
SCHEMBL3030476 0.76 HSD11B1 (0.38) MDM2FABP7FABP5SMN1; SMN2KMT2A
SCHEMBL1256558 0.75 OPRD1 (0.48) OPRD1OPRK1OPRM1FABP7FABP5
SCHEMBL4630456 0.72 OPRD1 (0.36) MDM2OPRD1OPRK1OPRM1FABP7
SCHEMBL3015083 0.71 MEN1 (0.43) OPRD1OPRK1OPRM1FABP7FABP5
SCHEMBL28864147 0.71 EPHX2 (0.44) FABP7FABP5LMNASMN1; SMN2KMT2A
SCHEMBL16004761 0.70 POLB (0.46) FABP7FABP5LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed